Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 651 across all filing types
Latest filing 2019-12-06 Investor Presentation
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a short announcement (under 1,000 characters) notifying the public of an upcoming Investor Relations (IR) event (Corporate Day). It provides the date, location, and purpose of the meeting, and mentions that the actual IR materials will be distributed on the day of the event. According to the 'Menu vs Meal' rule, since this is an announcement of an event/presentation rather than the presentation itself, it is classified as a Report Publication Announcement (RPA).
2019-12-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when a person or entity acquires a significant stake (typically 5% or more) in a company. This document details the shareholding status, changes in ownership, and contractual relationships (such as pledges or loans) of the major shareholder and their special related parties. It is a standard regulatory disclosure form, not an annual report, earnings release, or announcement of a report.
2019-12-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual relationships (such as pledges and loans) of a major shareholder (Gem & Company) and its special related parties in the company GemVax & Kael. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-11-25 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'GemVax & KAEL' covering the period from January 1, 2019, to September 30, 2019. It contains detailed corporate information, capital changes, shareholding structure, and governance details, which are characteristic of a formal quarterly financial report filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It is not an announcement or a summary, but the full report itself. 9M 2019
2019-11-14 Korean
[기재정정]분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for GemVax & KAEL, covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, business descriptions, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an entity or individual crosses a significant ownership threshold (typically 5%) in a listed company. In the provided taxonomy, this corresponds to 'Major Shareholding Notification' (MRQ). The document details the reporting entity, special related parties, the number of shares held, the purpose of holding, and changes in shareholding due to transactions like call option exercises and convertible bond conversions.
2019-11-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.